Athena Security Introduces Real-Time Weapons Detection Support Center
Athena Security Launches Weapons Detection Support Center to Proactively Diagnose and Resolve System Issues in Real Time Athena Security today announced the launch of its AI-enabled Weapons Detection Support Center, a built-in operational capability that proactively identifies, diagnoses, and resolves…
Coya Therapeutics Schedules Webinar with Medical Experts on ALS Research and Clinical Progress
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative…
Innovate 32 Teams Up with Trivette Osborne & Associates to Grow Tennessee Dental Presence
Innovate 32 Partners with Trivette Osborne & Associates, Expanding its Dental Services Presence in Tennessee Innovate 32 a rapidly expanding, partner-driven dental services organization, announced its partnership with Trivette Osborne & Associates, DDS, PLLC (“T&O”), a leading provider of comprehensive dental…
Evommune Shares Positive Phase 2a Top-Line Data for EVO301 in Atopic Dermatitis
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis Evommune, Inc. a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced positive top-line results from its…
EoS Fitness Celebrates Valentine’s Day with Complimentary Workouts
Feel the Love with Free Workouts at EoS Fitness this Valentine’s Day EoS Fitness, the national High Value. Low Price.®(HVLP) gym chain, is giving Valentine’s Day a modern makeover by opening all its gyms to the public for free on Saturday,…
AlphaLab Selects 20 Startups for Its 2026 Cohort Focused on Embedding Intelligence Across Industries
AlphaLab Selects 20 Startups for 2026 Cohort Embedding Intelligence Into Industry AlphaLab, the accelerator of Innovation Works helping entrepreneurs accelerate their path to market, has selected 20 companies to join its 2026 cohort, marking the largest group of startups the program has…
Calla Lily Clinical Care and Merck Team Up to Develop Intravaginal Drug Delivery Technology
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to support…
ZOLL’s New Zenix Monitor/Defibrillator Receives MDR Approval
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device…
ZCG-Backed Unimed Completes Acquisition of Regenboog Shipping Pharmacy
ZCG-Backed Unimed Acquires Regenboog Shipping Pharmacy Universal Maritime Solutions a leading global provider of medical and compliance solutions to the maritime industry, today announced the acquisition of Regenboog Shipping Pharmacy, a Netherlands-based distributor of pharmaceutical products and medical devices serving the maritime sector.…
bioAffinity Technologies Names Leading Pulmonary and Lung Cancer Experts to Advisory Board
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board bioAffinity Technologies, Inc. a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced new appointments to its Medical and Scientific Advisory…
NextPoint Therapeutics Announces Clinical Debut of Novel NPX372 for Solid Tumor Treatment
NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors NextPoint Therapeutics, a clinical-stage biotechnology company developing a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis, today announced…
Median Technologies Achieves FDA Clearance for Groundbreaking AI Lung Cancer Screening Technology
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening Median Technologies developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early…